Attenuation of phosphoinositide 3-kinase δ signaling restrains autoimmune disease
- 1 June 2012
- journal article
- research article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 38 (4) , 381-391
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- p110δ Phosphoinositide 3-Kinase Represses IgE Switch by Potentiating BCL6 ExpressionThe Journal of Immunology, 2012
- B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient miceProceedings of the National Academy of Sciences, 2011
- Phosphoinositide 3-kinase δ regulates membrane fission of Golgi carriers for selective cytokine secretionJournal of Cell Biology, 2010
- The PI3K Isoforms p110α and p110δ Are Essential for Pre–B Cell Receptor Signaling and B Cell DevelopmentScience Signaling, 2010
- Myeloid cells, BAFF, and IFN-γ establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient miceJournal of Experimental Medicine, 2010
- Multiple roles of Lyn kinase in myeloid cell signaling and functionImmunological Reviews, 2009
- The p110δ of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generationJournal of Experimental Medicine, 2008
- Role of PI3Kδ and PI3Kγ in inflammatory arthritis and tissue localization of neutrophilsEuropean Journal of Immunology, 2008
- Role of the phosphoinositide 3‐kinase p110δ in generation of type 2 cytokine responses and allergic airway inflammationEuropean Journal of Immunology, 2007
- The duplicitous nature of the Lyn tyrosine kinase in growth factor signalingGrowth Factors, 2006